3 Year Absolute Returns
65.35% ↑
NAV (₹) on 21 Oct 2026
31.20
1 Day NAV Change
-0.59%
Risk Level
Very High Risk
Rating
-
LIC MF Healthcare Fund is a Equity mutual fund categorized under Sector, offered by LIC Mutual Fund Asset Management Limited. Launched on 08 Feb 2019, investors can start with a minimum SIP of ₹100 or ... Read more
AUM
₹ 99.36 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 62.72% |
| Hospitals & Medical Services | 29.83% |
| Chemicals - Others | 4.98% |
| Treps/Reverse Repo | 2.57% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 9.59% | ₹ 9.53 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 9.07% | ₹ 9.01 | Pharmaceuticals |
| Neuland Laboratories Ltd. | 6.14% | ₹ 6.10 | Pharmaceuticals |
| Torrent Pharmaceuticals Ltd. | 6.04% | ₹ 6 | Pharmaceuticals |
| Apollo Hospitals Enterprise Ltd. | 5.75% | ₹ 5.72 | Hospitals & Medical Services |
| Aurobindo Pharma Ltd. | 5.23% | ₹ 5.19 | Pharmaceuticals |
| Navin Fluorine International Ltd. | 4.98% | ₹ 4.95 | Chemicals - Others |
| Zydus Lifesciences Ltd. | 4.97% | ₹ 4.94 | Pharmaceuticals |
| Aster DM Quality Care Ltd. | 4.61% | ₹ 4.58 | Hospitals & Medical Services |
| Fortis Healthcare Ltd. | 3.77% | ₹ 3.74 | Hospitals & Medical Services |
| Metropolis Healthcare Ltd. | 3.35% | ₹ 3.33 | Hospitals & Medical Services |
| Gland Pharma Ltd. | 3.20% | ₹ 3.18 | Pharmaceuticals |
| Mankind Pharma Ltd. | 3.11% | ₹ 3.09 | Pharmaceuticals |
| Nephrocare Health Services Ltd. | 3.05% | ₹ 3.03 | Hospitals & Medical Services |
| Max Healthcare Institute Ltd. | 2.99% | ₹ 2.98 | Hospitals & Medical Services |
| Cohance Lifesciences Ltd. | 2.95% | ₹ 2.93 | Pharmaceuticals |
| Glenmark Pharmaceuticals Ltd. | 2.61% | ₹ 2.59 | Pharmaceuticals |
| Global Health Ltd. | 2.59% | ₹ 2.58 | Hospitals & Medical Services |
| Treps | 2.57% | ₹ 2.55 | Others |
| Dr Agarwal's Health Care Ltd. | 2.46% | ₹ 2.44 | Hospitals & Medical Services |
| Biocon Ltd. | 2.37% | ₹ 2.35 | Pharmaceuticals |
| IPCA Laboratories Ltd. | 2.33% | ₹ 2.31 | Pharmaceuticals |
| Onesource Specialty Pharma Ltd. | 2.30% | ₹ 2.28 | Pharmaceuticals |
| Piramal Pharma Ltd. | 1.43% | ₹ 1.43 | Pharmaceuticals |
| Syngene International Ltd. | 1.38% | ₹ 1.37 | Pharmaceuticals |
| Artemis Medicare Services Ltd. | 1.26% | ₹ 1.25 | Hospitals & Medical Services |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 13.14% | 3.40% | 2.27% | 18.25% |
| Category returns | 3.14% | -1.22% | 1.10% | 18.59% |
The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹34.47 | 97.94% | 295.52% | 0.00% | ₹1,147 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹34.47 | 97.94% | 295.52% | 0.00% | ₹1,147 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹34.47 | 97.94% | 295.52% | 0.00% | ₹1,147 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.14 | 95.31% | 279.57% | 0.00% | ₹1,147 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.14 | 95.31% | 279.57% | 0.00% | ₹1,147 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.14 | 95.31% | 279.57% | 0.00% | ₹1,147 | 2.34% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.34 | 15.31% | 139.64% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.34 | 15.31% | 139.64% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.34 | 15.31% | 139.64% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹28.27 | 14.21% | 132.02% | 0.00% | ₹11,493 | 1.79% |
Very High
|
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
LIC MF Gold ETF
ETF
Regular
|
₹128.67 | 12.58% | 131.74% | 193.25% | ₹1,441 | 0.45% |
High
|
|
LIC MF Gold ETF FOF - Direct Plan
Fund of Funds
Direct
|
₹38.96 | 12.08% | 129.14% | 189.25% | ₹833 | 0.35% |
High
|
|
LIC MF Gold ETF FOF
Fund of Funds
Regular
|
₹36.82 | 11.77% | 126.59% | 183.71% | ₹833 | 0.61% |
High
|
|
LIC MF Infrastructure Fund - Direct Plan
Sector
Direct
|
₹59.23 | 2.86% | 74.07% | 148.41% | ₹1,153 | 1.33% |
Very High
|
|
LIC MF Infrastructure Fund - Direct Plan
Sector
Direct
|
₹58.15 | 2.86% | 73.97% | 147.39% | ₹1,153 | 1.33% |
Very High
|
|
LIC MF Infrastructure Fund - Direct Plan
Sector
Direct
|
₹58.15 | 2.86% | 73.97% | 147.39% | ₹1,153 | 1.33% |
Very High
|
|
LIC MF Healthcare Fund - Direct Plan
Sector
Direct
|
₹34.62 | 4.78% | 71.74% | 72.69% | ₹99 | 1.37% |
Very High
|
|
LIC MF Healthcare Fund - Direct Plan
Sector
Direct
|
₹34.61 | 4.78% | 71.69% | 72.64% | ₹99 | 1.37% |
Very High
|
|
LIC MF Healthcare Fund - Direct Plan
Sector
Direct
|
₹34.61 | 4.78% | 71.69% | 72.64% | ₹99 | 1.37% |
Very High
|
|
LIC MF Infrastructure Fund
Sector
Regular
|
₹50.94 | 1.49% | 67.30% | 133.44% | ₹1,153 | 2.67% |
Very High
|
What is the current NAV of LIC MF Healthcare Fund Regular Growth?
What is the fund size (AUM) of LIC MF Healthcare Fund Regular Growth?
What are the historical returns of LIC MF Healthcare Fund Regular Growth?
What is the risk level of LIC MF Healthcare Fund Regular Growth?
What is the minimum investment amount for LIC MF Healthcare Fund Regular Growth?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article